| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | May 14, 2024 | Option Exercise | $163.34 | 534 | 87,224 | 23,726 | May 15, 2024, 08:17 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Mar 11, 2024 | Sale | $193.73 | 3,517 | 681,348 | 24,260 | Mar 12, 2024, 08:24 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Mar 11, 2024 | Option Exercise | $86.10 | 1,271 | 109,433 | 27,777 | Mar 12, 2024, 08:24 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Mar 07, 2024 | Option Exercise | $195.72 | 386 | 75,548 | 26,506 | Mar 07, 2024, 04:27 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Mar 04, 2024 | Option Exercise | $193.99 | 135 | 26,189 | 26,892 | Mar 06, 2024, 08:01 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Mar 01, 2024 | Option Exercise | $191.79 | 453 | 86,881 | 27,027 | Mar 04, 2024, 09:51 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | May 16, 2023 | Option Exercise | $154.03 | 710 | 109,361 | 23,556 | May 16, 2023, 07:01 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Mar 03, 2023 | Option Exercise | $188.00 | 1,247 | 234,436 | 24,266 | Mar 06, 2023, 05:31 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Feb 28, 2023 | Option Exercise | $173.28 | 358 | 62,034 | 18,454 | Mar 01, 2023, 05:32 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Feb 28, 2023 | Option Exercise | $173.44 | 458 | 79,436 | 18,812 | Feb 28, 2023, 07:46 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Aug 11, 2022 | Option Exercise | $50.58 | 4,000 | 202,311 | 24,110 | Aug 12, 2022, 04:49 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Aug 11, 2022 | Sale | $254.32 | 4,840 | 1,230,886 | 23,310 | Aug 12, 2022, 04:49 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | May 13, 2022 | Option Exercise | $150.40 | 712 | 107,085 | 20,110 | May 17, 2022, 05:00 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Feb 27, 2022 | Option Exercise | $196.70 | 477 | 93,826 | 18,645 | Mar 02, 2022, 08:19 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Feb 28, 2022 | Option Exercise | $196.70 | 2,057 | 404,612 | 20,822 | Mar 02, 2022, 08:19 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Feb 24, 2022 | Option Exercise | $189.21 | 188 | 35,571 | 19,122 | Feb 28, 2022, 07:10 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Feb 17, 2022 | Option Exercise | $182.42 | 175 | 31,923 | 17,184 | Feb 22, 2022, 07:34 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Dec 14, 2021 | Option Exercise | $252.53 | 445 | 112,376 | 16,909 | Dec 15, 2021, 09:30 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Aug 30, 2021 | Sale | $282.13 | 4,001 | 1,128,802 | 17,354 | Sep 02, 2021, 06:54 AM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Jun 10, 2021 | Option Exercise | $67.23 | 3,602 | 242,167 | 28,157 | Jun 14, 2021, 06:48 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Jun 10, 2021 | Sale | $189.19 | 6,802 | 1,286,870 | 21,355 | Jun 14, 2021, 06:48 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | May 14, 2021 | Sale | $172.29 | 710 | 122,326 | 24,555 | May 18, 2021, 07:50 AM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Mar 10, 2021 | Option Exercise | $34.15 | 8,000 | 273,167 | 33,265 | Mar 12, 2021, 07:33 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Mar 10, 2021 | Sale | $190.44 | 8,000 | 1,523,501 | 26,911 | Mar 12, 2021, 07:33 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Mar 04, 2021 | Sale | $192.00 | 2,075 | 398,395 | 26,940 | Mar 08, 2021, 09:41 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Dec 16, 2020 | Sale | $186.18 | 435 | 80,988 | 25,654 | Dec 18, 2020, 04:30 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Aug 06, 2020 | Option Exercise | $33.87 | 5,000 | 169,350 | 31,089 | Aug 10, 2020, 05:35 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Aug 06, 2020 | Sale | $153.79 | 5,000 | 768,950 | 26,089 | Aug 10, 2020, 05:35 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | May 15, 2020 | Sale | $140.69 | 435 | 61,200 | 26,089 | May 19, 2020, 08:54 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | May 13, 2020 | Option Exercise | $33.25 | 8,000 | 266,040 | 34,524 | May 15, 2020, 05:37 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | May 13, 2020 | Sale | $127.80 | 8,000 | 1,022,373 | 32,912 | May 15, 2020, 05:37 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Mar 03, 2020 | Sale | $88.35 | 450 | 39,757 | 29,079 | Mar 05, 2020, 05:53 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Mar 04, 2020 | Sale | $90.76 | 2,555 | 231,888 | 28,429 | Mar 05, 2020, 05:53 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Feb 26, 2020 | Sale | $86.60 | 195 | 16,887 | 26,313 | Feb 27, 2020, 05:38 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Dec 16, 2019 | Option Exercise | $90.43 | 295 | 26,677 | 26,508 | Dec 18, 2019, 04:16 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Mar 05, 2019 | Sale | $58.53 | 2,240 | 131,107 | 18,803 | Mar 05, 2019, 05:34 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Feb 28, 2019 | Sale | $59.16 | 185 | 10,945 | 16,343 | Mar 04, 2019, 06:52 PM | |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Dec 18, 2018 | Sale | $54.44 | 311 | 16,931 | 12,294 | Dec 20, 2018, 04:22 PM |
Menu